Research map: Systemic evaluation and optimisation strategies for the synergy of high-value medical consumables policies in China

Back to the article

Papers in this map

  1. Evolving Use of Health Technology Assessment in Medical Device Procurement—Global Systematic Review: An ISPOR Special Interest Group Report · Michael J. Cangelosi · 2023 · 17 citations · Cited by this paper
  2. Cost-utility and budget impact analysis of herpes zoster vaccines in Thai patients with end-stage renal disease · 2026 · Related
  3. Securing Medical Supply Chains in a Post-Pandemic World · OECD · 2024 · 11 citations · Cited by this paper
  4. Effectiveness of person-centred versus usual care in elderly patients: findings from a multicentre randomised controlled trial · 2026 · Related
  5. Use of intravenous antibiotics for the management of suspected chorioamnionitis: insights from women's wellness and research center · 2026 · Related
  6. The impact of China’s National Drug Centralized Procurement Policy on pharmaceutical firm innovation: evidence from a staggered difference-in-differences analysis · 2026 · Related
  7. The Saudi FDA drug evaluation timeline in comparison with international counterparts: a retrospective observational study · 2026 · Related
  8. Community pharmacy based point-of-care testing for early detection of undiagnosed type 2 diabetes mellitus: a study protocol · 2026 · Related
  9. Landscape of national antibiotic utilisation in Malaysia: an analysis of national pharmaceutical sales data from 2019 to 2023 · 2026 · Related
  10. Reconstructing the professional role of pharmacists in China from the perspective of public value theory: challenges and institutional pathways · 2026 · Related
  11. Economic burden and health utility of transfusion-dependent beta-thalassemia in Thai adults: a societal perspective · 2026 · Related
  12. A scoping review of the views and experiences of health professionals in the Middle East and North Africa regions regarding social media use · 2026 · Related

Source: OpenAlex (CC0)